1
|
Zhu J, Jiang X, Luo X, Zhao R, Li J, Cai H, Ye XY, Bai R, Xie T. Combination of chemotherapy and gaseous signaling molecular therapy: Novel β-elemene nitric oxide donor derivatives against leukemia. Drug Dev Res 2023. [PMID: 36988106 DOI: 10.1002/ddr.22051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2022] [Revised: 02/06/2023] [Accepted: 03/09/2023] [Indexed: 03/30/2023]
Abstract
This study aimed to design and synthesize active hybrids of β-elemene and nitric oxide (NO) donor pharmacophore as potential agents for treating leukemia. Derivatives reported herein exerted better inhibitory effects against human chronic myeloid leukemia K562 cells compared to β-elemene (IC50 > 100 μM). The most potent compound 18f showed an IC50 value of 0.53 μM against K562 cells, as well as a high NO release level in vitro. In the K562 xenograft tumor mice model, compound 18f effectively inhibited the growth of the tumor, with a significant inhibition rate of 73.18%. After treatment with compound 18f, the body weight of mice did not decrease, indicating that it possessed good safety profile. All these proved that compound 18f was an excellent potential agent against leukemia.
Collapse
Affiliation(s)
- Junlong Zhu
- School of Pharmacy, Hangzhou Normal University, Hangzhou, People's Republic of China
- Key Laboratory of Elemene Class Anti-cancerAnti-cancer Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, People's Republic of China
| | - Xiaoying Jiang
- School of Pharmacy, Hangzhou Normal University, Hangzhou, People's Republic of China
- Key Laboratory of Elemene Class Anti-cancerAnti-cancer Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, People's Republic of China
| | - Xinyu Luo
- School of Pharmacy, Hangzhou Normal University, Hangzhou, People's Republic of China
- Key Laboratory of Elemene Class Anti-cancerAnti-cancer Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, People's Republic of China
| | - Rui Zhao
- School of Pharmacy, Hangzhou Normal University, Hangzhou, People's Republic of China
- Key Laboratory of Elemene Class Anti-cancerAnti-cancer Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, People's Republic of China
| | - Junjie Li
- School of Pharmacy, Hangzhou Normal University, Hangzhou, People's Republic of China
- Key Laboratory of Elemene Class Anti-cancerAnti-cancer Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, People's Republic of China
| | - Hong Cai
- School of Pharmacy, Hangzhou Normal University, Hangzhou, People's Republic of China
- Key Laboratory of Elemene Class Anti-cancerAnti-cancer Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, People's Republic of China
| | - Xiang-Yang Ye
- School of Pharmacy, Hangzhou Normal University, Hangzhou, People's Republic of China
- Key Laboratory of Elemene Class Anti-cancerAnti-cancer Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, People's Republic of China
| | - Renren Bai
- School of Pharmacy, Hangzhou Normal University, Hangzhou, People's Republic of China
- Key Laboratory of Elemene Class Anti-cancerAnti-cancer Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, People's Republic of China
| | - Tian Xie
- School of Pharmacy, Hangzhou Normal University, Hangzhou, People's Republic of China
- Key Laboratory of Elemene Class Anti-cancerAnti-cancer Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Hangzhou Normal University, Hangzhou, People's Republic of China
- Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, People's Republic of China
| |
Collapse
|